A micrometeorite record in Ordovician Durness Group limestones, Isle of Skye

Peer reviewed

Tourism and sustainable development on the Isle of Eigg, Scotland

Acknowledgements Although this paper is not linked to any of the research carried out by, or on behalf of, the James Hutton Institute, some parts of it were written during the first author’s allocated work time. Rachel Creaney is grateful to the James Hutton Institute for giving her this opportunity. The authors would also like to thank Dr Tavis Potts (University of Aberdeen) for proofreading the first draft of the paper and providing valuable comments on its flow, structure and contents. Finally, the authors are grateful to Emily Hastings and Doug Wardell-Johnson from the James Hutton Institute for their assistance with obtaining some of the data used in this paper.

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years : 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Acknowledgments The VIVIANE study was funded and coordinated by GlaxoSmithKline Biologicals SA, which also covered all costs associated with development and publication of this report. We thank all study participants and their families. We gratefully acknowledge the work of the central and local study coordinators, and staff members of the sites who participated in this study. Writing support services were provided by Mary Greenacre (An Sgriobhadair, Isle of Barra, UK), on behalf of GSK Vaccines; editing and publication coordination services were provided by Jérôme Leemans (Keyrus Biopharma, Lasne, Belgium), Stéphanie Delval (XPE Pharma and Science, Wavre, Belgium), and Matthieu Depuydt (Business Decision Life Sciences, Brussels, Belgium), on behalf of GSK Vaccines